Boston Scientific Corporation (BSX)

US — Healthcare Sector

Peers: SYK MDT DHR GILD PFE AMGN ABT SNY HCA MCK

Automate Your Wheel Strategy on BSX

With Tiblio's Option Bot, you can configure your own wheel strategy including BSX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol BSX
Rev/Share 13.0593
Book/Share 15.2885
PB 6.7138
Debt/Equity 0.5365
CurrentRatio 1.3721
ROIC 0.0775

MktCap 150586462322.0
FreeCF/Share 2.2346
PFCF 45.4807
PE 53.9853
Debt/Assets 0.2894
DivYield 0
ROE 0.128

Rating C-
Score 1
Recommendation Strong Sell
P/E Score 1
DCF Score 4
P/B Score 1
D/E Score 1

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
Downgrade	BSX	Erste Group	Buy	Hold	--	--	Oct. 3, 2025
Upgrade	BSX	Oppenheimer	Perform	Outperform	--	$125	Sept. 8, 2025
Initiation	BSX	Leerink Partners	--	Outperform	--	$118	June 16, 2025
Upgrade	BSX	Needham	Hold	Buy	--	$113	April 16, 2025
Upgrade	BSX	Deutsche Bank	Hold	Buy	--	$108	Jan. 10, 2025
Downgrade	BSX	Needham	Buy	Hold	--	--	Oct. 18, 2024

News

Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term

BSX
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

image for news Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term

Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?

BSX
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?

Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term

BSX
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term

Boston Scientific's Margins Strengthen in Q3: What's Driving It?

BSX
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive

BSX posts stronger Q3 margins as growth in EP and WATCHMAN lifts product mix despite tariff pressure.

image for news Boston Scientific's Margins Strengthen in Q3: What's Driving It?

BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?

BSX, EW
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive

Boston Scientific's EP breadth, WATCHMAN momentum and acquisitions give it an edge over Edwards in cardiovascular devices.

image for news BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?

Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know

BSX
Published: November 21, 2025 by: Zacks Investment Research
Sentiment: Positive

Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know

PAHC or BSX: Which Is the Better Value Stock Right Now?

BSX, PAHC
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Neutral

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?

image for news PAHC or BSX: Which Is the Better Value Stock Right Now?

Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

BSX
Published: November 18, 2025 by: Seeking Alpha
Sentiment: Neutral

Boston Scientific Corporation ( BSX ) 7th Annual Wolfe Research Healthcare Conference November 18, 2025 8:00 AM EST Company Participants Ken Stein - Senior VP & Global Chief Medical Officer Lauren Tengler - Director of Investor Relations Conference Call Participants Michael Polark - Wolfe Research, LLC Presentation Michael Polark Wolfe Research, LLC Good morning. Welcome, everybody.

image for news Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Wall Street Analysts Believe Boston Scientific (BSX) Could Rally 25.34%: Here's is How to Trade

BSX
Published: November 18, 2025 by: Zacks Investment Research
Sentiment: Positive

The consensus price target hints at a 25.3% upside potential for Boston Scientific (BSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Believe Boston Scientific (BSX) Could Rally 25.34%: Here's is How to Trade

4 Medical Product Stocks to Watch From a Challenging Industry

ALUR, BLFS, BSX, PODD
Published: November 17, 2025 by: Zacks Investment Research
Sentiment: Negative

The Zacks Medical products industry sees steady demand, but macro headwinds keep growth under pressure in 2025. BSX, PODD, BLFS and ALUR reflect the favorable fundamentals.

image for news 4 Medical Product Stocks to Watch From a Challenging Industry

Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors

BSX
Published: November 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Boston Scientific (BSX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, BSX crossed above the 200-day moving average, suggesting a long-term bullish trend.

image for news Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors

Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet

BSX
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Neutral

Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes"

BSX
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive

Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.

image for news Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?

BSX
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive

BSX's Q3 EP sales soar 63% on FARAPULSE momentum, FDA label expansion and rising global adoption.

image for news Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?

Bet on 5 Top-Ranked Stocks With Rising P/E

BSX, CHEF, CRMD, HNST, LTH
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include The Chef's Warehouse, Life Time Group Holdings, The Honest Company, CorMedix and Boston Scientific.

image for news Bet on 5 Top-Ranked Stocks With Rising P/E

Demographic Megatrend: Stocks Poised to Benefit From Global Aging

ABBV, AMGN, BSX, EW
Published: October 31, 2025 by: Zacks Investment Research
Sentiment: Positive

Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this powerful megatrend.

image for news Demographic Megatrend: Stocks Poised to Benefit From Global Aging

Baron Health Care Fund Q3 2025 Top Contributors And Detractors

ARGX, BSX, INSM, ISRG, LLY, RDNT
Published: October 27, 2025 by: Seeking Alpha
Sentiment: Neutral

Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. RadNet, Inc. is the largest operator of outpatient diagnostic imaging services and related solutions in the U.S. Intuitive Surgical, Inc. manufactures the da Vinci Surgical System, a robotic surgical system used for minimally invasive surgical procedures.

image for news Baron Health Care Fund Q3 2025 Top Contributors And Detractors

PAHC vs. BSX: Which Stock Is the Better Value Option?

BSX, PAHC
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?

image for news PAHC vs. BSX: Which Stock Is the Better Value Option?

Does Boston Scientific (BSX) Have the Potential to Rally 25.61% as Wall Street Analysts Expect?

BSX
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive

The consensus price target hints at a 25.6% upside potential for Boston Scientific (BSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.